633 related articles for article (PubMed ID: 20179693)
1. Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population.
Schmulson M; Adeyemo M; Gutiérrez-Reyes G; Charúa-Guindic L; Farfán-Labonne B; Ostrosky-Solis F; Díaz-Anzaldúa A; Medina L; Chang L
Am J Gastroenterol; 2010 Apr; 105(4):925-32. PubMed ID: 20179693
[TBL] [Abstract][Full Text] [Related]
2. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
[TBL] [Abstract][Full Text] [Related]
3. [Quality of life at dyspepsia and irritable bowel syndrome: population-based studies].
Reshetnikov OV; Kurilovich SA; Simonova GI; Pylenkova ED; Maliutina SK
Eksp Klin Gastroenterol; 2010; (3):27-31. PubMed ID: 20496786
[TBL] [Abstract][Full Text] [Related]
4. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.
Corsetti M; Caenepeel P; Fischler B; Janssens J; Tack J
Am J Gastroenterol; 2004 Jun; 99(6):1152-9. PubMed ID: 15180740
[TBL] [Abstract][Full Text] [Related]
5. Functional dyspepsia and irritable bowel syndrome in patients with achalasia and its association with non-cardiac chest pain and a decreased health-related quality of life.
Frankhuisen R; Van Herwaarden MA; Heijkoop R; Baron A; Vermeijden R; Smout AJ; Gooszen HG; Samsom M
Scand J Gastroenterol; 2009; 44(6):687-91. PubMed ID: 19263270
[TBL] [Abstract][Full Text] [Related]
6. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus.
Neumann H; Monkemuller K; Kandulski A; Malfertheiner P
Dig Dis; 2008; 26(3):243-7. PubMed ID: 18463443
[TBL] [Abstract][Full Text] [Related]
7. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
[TBL] [Abstract][Full Text] [Related]
8. Frequency of functional bowel disorders among healthy volunteers in Mexico City.
Schmulson M; Ortíz O; Santiago-Lomeli M; Gutiérrez-Reyes G; Gutiérrez-Ruiz MC; Robles-Díaz G; Morgan D
Dig Dis; 2006; 24(3-4):342-7. PubMed ID: 16849861
[TBL] [Abstract][Full Text] [Related]
9. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
[TBL] [Abstract][Full Text] [Related]
10. Gender-related differences in visceral perception in health and irritable bowel syndrome.
Kim HS; Rhee PL; Park J; Lee JH; Kim YH; Kim JJ; Rhee JC
J Gastroenterol Hepatol; 2006 Feb; 21(2):468-73. PubMed ID: 16509877
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome.
Ringel Y; Williams RE; Kalilani L; Cook SF
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):68-72; quiz 3. PubMed ID: 19124113
[TBL] [Abstract][Full Text] [Related]
12. Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: focus on pain perception.
Kim ES; Cheon JH; Park JJ; Moon CM; Hong SP; Kim TI; Kim WH
J Gastroenterol Hepatol; 2010 Jul; 25(7):1232-8. PubMed ID: 20594249
[TBL] [Abstract][Full Text] [Related]
13. Irritable bowel syndrome: a population based study.
Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
15. Value of different diagnostic criteria for the irritable bowel syndrome among men and women.
Hammer J; Talley NJ
J Clin Gastroenterol; 2008 Feb; 42(2):160-6. PubMed ID: 18209586
[TBL] [Abstract][Full Text] [Related]
16. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping.
Nakajima S; Takahashi K; Sato J; Fukuda M; Yamamoto K; Inoue T; Okumura Y; Fujiyama Y
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S138-43. PubMed ID: 20586856
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria.
Han SH; Lee OY; Bae SC; Lee SH; Chang YK; Yang SY; Yoon BC; Choi HS; Hahm JS; Lee MH; Lee DH; Kim TH
J Gastroenterol Hepatol; 2006 Nov; 21(11):1687-92. PubMed ID: 16984590
[TBL] [Abstract][Full Text] [Related]
18. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis?
Holtmann G; Goebell H; Talley NJ
Am J Gastroenterol; 1997 Jun; 92(6):954-9. PubMed ID: 9177509
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study.
Lee SY; Lee KJ; Kim SJ; Cho SW
Digestion; 2009; 79(3):196-201. PubMed ID: 19342860
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.
Hillilä MT; Färkkilä MA
Aliment Pharmacol Ther; 2004 Aug; 20(3):339-45. PubMed ID: 15274671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
